On 23rd March, the Government demanded that the majority of public-facing businesses close their doors. Veterinary surgeries, however, have been exempted and are allowed to remain open.
However, the number of clients seen face-to-face should be kept to an absolute minimum and veterinary teams must insist on strict social distancing measures at all times.
In addition, the RCVS/BVA say that:
The College has updated its FAQs for veterinary professionals, which can be found here: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
The BVA is now developing some further guidance to provide examples of what constitutes routine, urgent and emergency care.
The centre was launched in February last year after an 8-month briefing and design period, followed by a 9-month construction and fit-out process.
Paragon and DesM also picked up the top prize in the Conversion category, awarded to practices which have made use of buildings previously used for other purposes.
John Marsh said: "Our aim was to build on our experience with two previous small animal hospitals for the RVC and Lower Langford Veterinary School, in designing a 'practitioners' answer' to veterinary care, but adapted to a more commercial facility, mindful of a practical but bright working environment for both the clinicians and owners, where it is a pleasure to work and a catalyst for enabling the best possible animal care."
Paragon managing director Ian Monteith said: "Every year, the BVHA seeks out and rewards the very best veterinary hospitals across the UK and we are delighted the high standards we set here at Paragon have been recognised.
"This is a terrific compliment to the very careful planning that went into designing the building and equipping it with the very latest equipment and technology."
In their report, the BVHA assessor said: "The premises are spectacular in design and appearance, creating an immediate impression of clinical excellence and quality patient care to both clients and visiting clinicians.
"The quality of the clinical work being undertaken was easy to see. There was a very positive attitude to training and induction routines, as well as mental health and team welfare."
There was one other category, for the best refurbishment, which was won by Vets Now’s hospital in Glasgow.
Lynne was instrumental in creating the Linnaeus business in January 2015, and then growing it to the point where it now has 145 veterinary practices across the UK.
Lynne will be staying on as a consultant for Mars Petcare, which acquired Linnaeus in June 2018. She said: "As much as I would love to be part of the continuing journey and success of Linnaeus, I feel it is right for me to step back from the total time commitment required to be a CEO."
Paul Coxon, Linnaeus Chief Financial Officer, said: "The Linnaeus Group’s achievements under Lynne’s leadership cannot be underestimated. Since 2015, there have been numerous development milestones and significant growth as we have welcomed a number of highly-regarded referral centres and exceptional first opinion brands to the Linnaeus family. Lynne leaves us with a great legacy and a very bright future."
Linnaeus is due to make an announcement on Mrs Hill’s successor shortly.
The company says the new product has been launched in response to demand from UK equine veterinary surgeons specialising in dentistry
Hexarinse for Horses is presented as a palatable, mint-flavoured, ready-to-use formulation in a five litre container.
Virbac says the antibacterial action of chlorhexidine supports the maintenance of oral health after dental procedures and may aid the management of periodontal disease, oral inflammation and the management of peripheral caries.
For further information, speak to your local Virbac territory manager or contact Virbac Limited on: 01359 243243 or enquiries@virbac.co.uk.
Ceva says the adverts, which will air on Channel 4 and Channel 4 partner channels until 20th January, will reach 15 million people. That might prove a conservative estimate though, because the Adaptil advert on YouTube has already had over 800,000 views, whilst the Feliway advertisement has had very nearly as many.
In addition, Adaptil has partnered with The Times to support its 'Walking the Dog' podcast series hosted by radio presenter and journalist Emily Dean.
During the podcasts, Emily talks with celebrities like Noel Fitzpatrick, Jimmy Carr, Rob Bryden and Jonathan Ross as they walk their dogs. An Adaptil advert airs at the start, middle and end of each podcast.
You can hear the podcasts on itunes here: https://itunes.apple.com/gb/podcast/walking-the-dog-with-emily-dean/id1220510307
Abigail King, behaviour product manager at Ceva Animal Health said: "Our new TV advertising campaigns and podcast partnership will boost awareness of both Adaptil and Feliway throughout the festive period and into January, when changes to routine, visitors in the household and loud noises from Christmas crackers and fireworks can challenge even the most laid-back pet."
For more information, visit: www.adaptil.com or www.feliway.com.
I had hoped that the increasing absurdity of the reasons given for the rise might have tipped everyone off to the fact that the story was a spoof.
The idea that the College would ask its members to fund some glitzy, showy, award-winning designer headquarters along the lines of London’s City Hall? C’mon. London City Hall employs 1000 staff, whilst the Royal College employs less than 100. And let's face it, the RCVS has no record of having showy offices. On the contrary, it has managed to operate out of a sardine can now for a great many years. Have you ever been in the lift at Horseferry Road? You need to breathe in.
Or that the College had set aside £6M to recruit and pay 20 veterinary surgeons as short term contracted OVs to help in the event of a no-deal Brexit. Let’s say a flight from Delhi to London costs £500, give or take. Twenty vets. That’s £10,000 to get them here. Let's say they’re here for 6 months. That’s £299,500 per vet. You really think the College is going to ask you to pay more than a quarter of a million pounds to fly in a single vet for 6 months? Or that 20 recruits would solve the predicted OV shortage?
Lastly, the quote, supposedly from an Indian vet, but one with a name that doesn’t really sound like a name (still less an Indian one), but does sound strangely like it may be an anagram of April Fool.
There have been a small number of reports of people being really upset by this story. I guess they must have skim read, or only read the headline.
To them I want to say sorry, I genuinely didn’t mean to upset anyone.
In fact, I thought it might cause some reflection on what good value the RCVS really offers. It maintains the register and thereby your ability to practice, it runs the disciplinary process (an essential component of maintaining public trust), it oversees and sets educational standards, it awards Fellowships, Diplomas and Certificates, it runs the Practice Standards Scheme.
All that, and more for £340 per annum?
Honestly? I think it would be cheap at half the price.
Photo: Truth is that the RCVS has operated out of a sardine can for years.By Rl - Own work, CC BY-SA 3.0, Link
A wild golden eagle, one of only 442 breeding pairs, has died after being confiscated from a falconry expert who was nursing the animal back to health, and placed in the care of the RSPCA instead.
Roy Lupton, a falconer from Kent, saved the eagle in November last year, after it sustained injuries fighting a friend's bird. According to newspaper reports, Mr Lupton was given permission by the Scottish Executive to take the bird back to his premises in Kent to nurse it back to health. He planned to release the bird in the spring and claims he told Defra of his plans. Nevertheless, on May 5th, his premises were raided by Kent police, a Defra official and an official from the RSPB.
Despite his protests, the bird was seized and taken to the RSPCA's Mallydam wildlife centre in Sussex. Mr Lupton was questioned by police and the case passed to the Crown Prosecution Service. It was later dropped.
Meanwhile, Mr Lupton was allowed to visit the bird at the wildlife centre. He said: "I was horrified by what I saw. The RSPCA was keeping the bird on a concrete floor, which is bad for its talons, and there was leaf mould on the roof of the room, which can cause lung infections in golden eagles."
Mr Lupton was later allowed to take the animal home. However, its condition had deteriorated badly, and on June 17th he took the animal to see avian vet Neil Forbes. Sadly, nothing could be done, and the animal died hours later.
In his autopsy report, Neil said that the bird was kept in inappropriate conditions while in the care of the RSPCA and was "not provided with good practice in terms of husbandry". He added: "Whilst I cannot be certain the bird’s death was a direct result of the Defra seizure and the period of RSPCA care, certainly the stress effect (suppressing the immune system), the persistent systemic infection from the time of leaving the RSPCA care, does indicate a very high likelihood of a causative link between the period of care and the bird’s subsequent death."
Merial has published figures which show that gutworm is seriously affecting dairy cow fertility in up to 80% of UK dairy herds1, in order to raise awareness of the damaging impact of Ostertagia ostertagi.
Sioned Timothy, veterinary adviser for Merial said: “The reduction in milk production from a gutworm infection is well documented2. Both animal health advisers (Suitably Qualified Persons – SQPs) and vets recognise the threat such infections cause. However, since cows often show no outward signs of disease, even in the face of a massive challenge, dairy farmers could unwittingly suffer heavy losses in milk yield, reduced fertility and increased heifer rearing costs at a time when they can least afford it.”
Merial points out that the extent of a herd’s gutworm exposure can be easily and simply assessed from a sample taken from the bulk milk tank – using the MOO Test. This test determines the amount of antibody to Osteragia ostertagi present in a sample, giving an assessment of the level of herd gutworm challenge.
The metabolic demands placed on cows during the post-calving period can lead to a negative energy balance, when energy gained from feed intake is less than that used for milk production. This natural ‘energy gap’ leads to weight loss; a parasite burden can make matters worse.
Sioned advises taking action to reduce the effect of this post-calving energy gap to maintain productivity levels. She said: “Management of cows in the weeks following calving should focus on maximising dry matter intake to correct the energy imbalance as quickly as possible. Studies have shown that cows treated for gutworm have improved appetites, and graze for up to an hour longer than untreated cows3. Grass is the cheapest form of nutrition so it makes sense to make the most of it.”
Merial also points towards studies which have shown that effective parasite control may have a beneficial effect4,5. Reduced body condition scores caused by the energy gap after calving may impact on reproductive parameters. In one study, cows treated for gutworm were back in calf 13 days sooner than untreated animals4.
Sioned said: "This has obvious implications for productivity. We need to look at employing a range of practical measures to ensure cows are as productive and efficient as possible, and this includes targeted worming where required.”
According to the company, effective parasite management of the replacement heifer during the rearing period is key to her future performance and productivity. Achieving breed-appropriate target weights throughout the rearing period is a crucial component of heifer rearing. The onset of puberty and the start of breeding are more closely linked to weight, body size and condition score than age. It is therefore critical to ensure that heifers reach approximately 60% of mature weight by 14 months of age in order to achieve a 24 month average age at calving.
Sioned said: “Losses in potential liveweight gain due to poor parasite control during a heifer’s first grazing season will not be recouped during the second year at grass6. She won’t catch up, and this will impact on her ability to meet important milestones.”
Getting heifers in-calf at the optimal time will help to reduce breeding costs and maximises the potential productive life of the animal. Heifers treated for gutworm have been shown to have a 20% higher conception rate at first service than untreated cattle2.
Merial says there is also evidence that parasite burdens exert physiological effects that directly impact on the parameters influencing performance and profitability of heifers, and increased mammary development and earlier onset of puberty have been observed in strategically wormed heifers in comparison to those left untreated7,8.
Sioned said: “Effective worming will mitigate the effect of parasites on fertility levels in growing cattle4, while still allowing them to build the necessary immunity required to prevent clinical disease in adulthood.”
References
Boehringer Ingelheim Vetmedica has launched Buscopan 20mg/ml injection, an antispasmodic treatment for use in cases of equine colic, and an aid to the symptomatic treatment of calf scour.
A sister product to Buscopan Compositum which contains both an antispasmodic and a non-steroidal component, Buscopan 20 contains only the antispasmodic component - hyoscine butylbromide.
Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "Our customers have been telling us for some time that they would really welcome a Buscopan formulation without an NSAID for use in horses and cattle. I'm pleased to say that it's finally here and I'm sure that Buscopan 20 will be a very welcome addition to the armoury of both equine and cattle practitioners."
Buscopan 20 is supplied in a 50ml multi-dose bottle, and is available in veterinary wholesalers now.
For further information, please call 01344 746959.
The 18,000 sq ft centre's facilities include a £1 million imaging suite with state-of-the-art MRI and CT scanners, five operating theatres and extensive kennelling facilities and cat wards. It is also equipped with fluoroscopy equipment with additional mobile C-arm, mobile digital radiography, a Phaco machine and Mindray WATO anaesthetic equipment.
A total of up to 80 staff will be employed at Paragon, including up to 18 referral veterinary surgeons and 32 nurses. Treatment will include ophthalmology, orthopaedics, soft tissue surgery, cardiology, neurology, medicine, oncology and dermatology.
The centre, which is part of Dewsbury-based Calder Vets, which has 12 practices across Yorkshire, is being led by managing director Ian Monteith and clinical director Adam Bell.
Adam said: "The opening of Paragon is the culmination of an 18-month project to bring the very best quality referral veterinary centre here to Wakefield.
"We’re delighted to open our doors and the team here at Paragon Veterinary Referrals are totally committed to, and looking forward to, providing excellent care for patients using the latest veterinary techniques."
For more information about the services Paragon will be offering, and for details of the vacancies on offer at the vet centre, as well as Continuing Professional Development (CPD) opportunities, visit www.paragonreferrals.co.uk.
CVS says there has been a steady increase in the number of clinicians offering peripatetic services on the premises of host practices in almost every area of clinical work, including surgery, cardiology, diagnostic imaging and dermatology. It's a model for improving patient access to more advanced levels of clinical care.
The company has appointed Ben Walton BVSc DSAS(Orth) MRCVS (pictured right), an RCVS Specialist in Small Animal Surgery (Orthopaedics) at Chestergates Veterinary Specialists, to head up the new network (called the Advanced Clinical Services Network, or ASCN). In a previous life, he offered a peripatetic surgery service in the North West of England and North Wales for several years.
Ben said: "I believe that the new network will deliver huge advantages to a number of stakeholders. The peripatetic model is an attractive proposition from a number of perspectives.
"For the host practices, is allows cases to be managed to a greater depth in-house, improving their service offering, and increasing opportunities for development of the practice team. It also allows the retention of revenue from these cases, which in turn justifies investment in facilities.
"For the client and patient, it improves the level of care that they receive at their home practice. Visiting clinicians bring expertise into practices through their own knowledge and experience, but also through development of the practice team, thus improving standards across the board."
Ben believes the model also offers better clinical career progression for experienced vets: "I believe that clinically-satisfying roles can be hard to come by at the moment.
"As a profession, we tend to be good at looking after our recent graduates. CVS, other large groups and independent practices have worked really hard on this over the last few years. There are also plenty of opportunities to develop your career on a management track, especially in the large groups.
"What there is a real lack of, though, are jobs that allow genuine clinical development. Many vets are well-supported to gain certificates and Advanced Practitioner status, but often there isn’t a satisfying caseload at the end of it.
"Within the new network, experienced vets will have a caseload that is predominantly or exclusively within their preferred discipline, and as they will be performing higher-value work than they would in a GP position, better remuneration packages will be justifiable. Ultimately, we want to be able reward experienced vets well, for doing a job that is clinically satisfying, and provides a valuable service to host practices and their clients."
CVS says it intends to develop the Advanced Clinical Services Network in multiple disciplines nationwide over the next few years.
Ben added: "Primarily, the ACSN is being established to service CVS practices, but we envisage that many of the services will also be available to non-CVS practices."
For more information, visit careerswithcvs.co.uk
IMV Technologies is a reproduction biotechnology company which has worked in the field of animal artificial insemination and embryo transfer for over 50 years, with operations in more than 130 countries and subsidiaries in the USA, India, China, Italy and the Netherlands.
The newly-formed IMV Imaging now has over 500 employees, which, it says, will make it better placed to deliver the best quality ultrasound, X-ray and three-dimensional veterinary-specific imaging equipment.
The directors and senior management team from BCF and ECM are remaining to lead IMV Imaging.
Alan Picken, CEO of IMV imaging said: "The merger and creation of IMV imaging is a very exciting development for our companies. Building on our strong legacy, it allows us to deliver a wider portfolio of products and services to our customers worldwide and ultimately to deliver improved animal care.”
The company says the product is highly effective against common bacteria including Staphylococci, Clostridia, Corynebacteria and Streptococci, and gram-negative bacteria including Bacteroides spp, Pasteurellae, and Proteus spp.
Clavubactin is available in a range of dose strengths to treat all sizes of patient. It is presented as a doubly divisible tablet for accurate and flexible dosing and to help avoid the development of antibiotic resistance associated with under dosing. The tablets come in blister packs of 10, designed to help reduce unnecessary exposure when dispensing in practice.
Dechra Brand Manager Carol Morgan said: "The introduction of Clavubactin to our antibiotic portfolio will give veterinary professionals even more choice of effective and targeted treatments in their day-to-day practice."
Merck has announced that its animal health division, formerly known as Intervet/Schering-Plough, has changed its name to MSD Animal Health in countries outside the United States and Canada from today.
Intervet/Schering Plough will now be known as Merck Animal Health in the United States and Canada.
Raul Kohan, President of Merck Animal Health said: "The name change reflects Merck's commitment to animal health and its complementary role to the overall business. We are unwavering in our commitment to veterinarians, producers, pet owners and society as a whole. We aim to generate additional value and sustained growth by continuing to provide integrated solutions with innovative animal health products and services to meet the evolving needs of our customers."
Mr. Kohan continued: "With the scientific and business backing of Merck, Merck Animal Health possesses the necessary mix of resources to enhance our position as an industry leader."
Merck says it values the diversification that Merck Animal Health brings to its portfolio, and sees growth opportunities in the business that can be leveraged across both animal and human health. The company intends to capitalize on Merck Animal Health's broad and innovative portfolio going forward, and to develop the unit into a best-in-class global animal health leader.
The name change follows the joint announcement on March 22, 2011 by Merck and sanofi-aventis that ended plans to form a new animal health joint venture. Both companies mutually decided to discontinue their agreement primarily because of the increasing complexity of implementing the proposed transaction.
Henry Schein, Inc. has announced the acquisition of Veterinary Instrumentation, the supplier of surgical instruments and implants to veterinary surgeons in the United Kingdom.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein said: "We are delighted to welcome this highly regarded company to the Henry Schein family, and very pleased that founder John Lapish and Managing Director Steve Fletcher will continue to drive the business forward.
"The success of Veterinary Instrumentation closely parallels the cornerstones of Henry Schein, including a deep understanding of customer needs, innovative solutions, superior product quality and customer service, and a trusted advisory relationship with our customers. Reinforcing our existing animal health business in the U.K., we look forward to strengthening our relationship with veterinary customers in this region, and bringing the Veterinary Instrumentation product portfolio of high-quality surgical specialties to a growing number of veterinarians across Europe, the United States and Australasia."
Veterinary Instrumentation was founded by John Lapish in 1986 in Sheffield, England, where the business and distribution operations are currently conducted from a single facility. Working as a small animal orthopaedic surgeon in the late 1970s, Mr. Lapish began designing and developing a range of instruments specifically for veterinary surgery, initially for his own use. As requests for these products increased, the market need became clear and Veterinary Instrumentation was formed, in particular to meet the needs of orthopaedic surgeons focused on small animals.
Mr Lapish said: "We look forward to contributing to the continued growth and success of a leading supplier of companion animal health products and services in the United Kingdom and to becoming part of a global leader in the distribution of health care products and services.
"The expertise that we bring in the area of veterinary surgical instruments will complement Henry Schein's broad offering, and our customers will benefit greatly from the global resources of a company that has quickly become an animal health care product and service leader on three continents."
With approximately 60 percent of sales in the U.K., and the balance split fairly evenly between Europe and the rest of the world, Veterinary Instrumentation has 20 employees, including a team of eight Veterinary Technicians who advise customers on the most appropriate procedures and instrumentation.
Veterinary Instrumentation sales for the 12 months ended September 30, 2011 were approximately £6.7 million ($10.8 million). Financial terms of the transaction were not disclosed.
VetSurgeon.org welcomed its 4000th member to the online community last night, and recorded it's 1 millionth page view since the site was first launched late in 2007.
Use of the site didn't really start to take off until after the installation of a state-of-the-art social networking software platform late in 2008, and the site is now well on target to reach it's 2 millionth page view well inside the next year.
There was another significant milestone last night when VetSurgeon.org was contacted by a solicitor and asked politely to remove a part of a forum post on the site. Unlike Private Eye, I don't have the resources to argue in court, so I removed the offending paragraph.
Whatever else, it's flattering that someone thinks the VetSurgeon community is now important enough to wheel out a solicitor. Still, I hope it doesn't become a regular occurance. It's something of a heart-stopping moment when the person at the other end of the telephone introduces themselves 'as the solicitor acting for ...'
The guidelines, launched during WSAVA World Congress 2018 in Singapore, aim to bridge differing perceptions of welfare around the world and help veterinary surgeons and nurses tackle the ethical questions and moral issues which impact welfare.
They also offer guidance to ensure that, in addition to providing physical health advice and therapy to their patients, veterinary surgeons and nurses can advocate for their psychological, social and environmental wellbeing.
Dr Shane Ryan, incoming President of the WSAVA and former Chair of the WSAVA Animal Wellness and Welfare Committee, said: "As veterinarians, our responsibility extends far beyond the physical health of our patients. Animal welfare as a science is a new and rapidly developing discipline and veterinarians need current, evidence-based invformation to enable them to maintain the highest welfare standards and to provide knowledgeable, accurate advice for pet owners and communities.
"Our new Guidelines provide recommendations, checklists and other tools to promote optimal levels of welfare throughout the veterinary visit. They also offer guidance on increasing welfare beyond the doors of the clinic through outreach activities.
"As levels of pet ownership increase in many regions of the world, including Asia, it is essential that veterinarians champion animal welfare and the WSAVA hopes that these new Guidelines will encourage our members to adopt best practice and set the highest standards.
"I would like to thank the members of the Animal Welfare Guidelines team, who worked so hard to create them and, of course, our sponsor, Waltham, whose constant support was instrumental in enabling us to deliver them."
The Animal Welfare Global Guidelines for Companion Animal Practitioners and the Veterinary Team are available for free download at: https://bit.ly/2D3RAoc.
The company says that the Phillips tuberculin gun is easier to use, clean and maintain than the most commonly used device, and it also offers practices doing government TB testing work the opportunity to make substantial savings on the cost of consumables.
Dave Gilbert MRCVS, director with Dairy Insight said: "There is no official requirement to use a single make of gun for TB testing work, so with tightening margins for work in this arena it makes sense for practices to explore valid cost-saving options.
"Having trialled this NJ Phillips gun over the last 12 months in our own farm practice we’ve been very pleased with it, particularly when it comes to changing needles. I’ve always found this process fiddly, especially when you have cold hands. We’ve also made substantial savings on consumables, which are over 70p per needle cheaper for the V-Grip."
The V-Grip is precision engineered for optimum dosing accuracy and comes with a visible chamber, to help ensure correct administration of tuberculin.
For more information, contact Dairy Insight at: info@dairyinsight.co.uk
Dermot Costello, a Shropshire practitioner, has been suspended by the RCVS Disciplinary Committee for 10 weeks after he admitted being dishonest with a client and falsifying records about the treatment of her dog.
Mr Costello faced four charges against him:
At the outset of the hearing, Mr Costelloe, a partner at a veterinary practice in Market Drayton, Shropshire, admitted all heads of charge against him.
Scruffy had been brought to Mr Costelloe for a consultation on 27 October 2014. He carried out a physical examination and arranged for radiographs and routine blood tests while also prescribing anti-inflammatory tablets for spondylosis. Scruffy was brought back to the practice on 30 October 2014 following the deterioration of her condition. Further assessment took place and an abdominal scan was arranged for the next day. She stayed at the practice overnight, but died at some point during the night of 30 to 31 October 2014.
A telephone call between Mrs Green and Mr Costelloe took place shortly after 8am on 31 October during which he told her that "they had struggled with Scruffy all night" and that, as they were speaking, Scruffy was on oxygen and struggling to breathe.
After Mrs Green said she wanted to come to the practice to be with her dog, Mr Costelloe told her to wait and that he would call her back in two minutes. He did so and told her Scruffy had died five minutes ago, when in fact she had died at some point between 11pm on 30 October and 8am on 31 October.
Mr Costelloe continued the deception at meetings with Mrs Green on 31 October and 19 November 2014 and she was given the falsified clinical records on 4 December 2014. Another meeting took place on 14 January 2015 where Mr Costelloe finally admitted his deception to her. This resulted in Mrs Green submitting a formal complaint to the RCVS on 23 February 2015. He admitted his deception to the College in writing on 4 August 2015.
The Committee decided that all four heads of charge amounted to disgraceful conduct in a professional respect as his actions contravened several sections of the Code of Professional Conduct for Veterinary Surgeons in relation to being open and honest with clients; keeping clear, accurate and detailed clinical records; and not engaging in any actions or behaviour that would likely bring the profession into disrepute or undermine public confidence in the profession.
The Committee noted that, in his statement, Mr Costelloe gave a number of reasons for his conduct, including concern over Mrs Green’s reaction to the death of her dog and concern for the young vet who was on duty when Scruffy died. However, the Committee considered that the need to be open and honest with his clients should have been put above the needs of his practice.
In considering its sanction against Mr Costelloe, the Committee heard mitigating evidence from four character witnesses called on his behalf, as well as a number of written testimonials, and also had regard to his evident remorse, shame and insight into his behaviour.
However, it also considered a number of aggravating factors, including the fact that the misconduct had premeditated elements, was sustained over a period of weeks, and constituted a clear breach of client trust.
The Committee decided that the most appropriate sanction was to suspend Mr Costelloe from the Register for a period of 10 weeks. Chitra Karve, chairing the Committee and speaking on its behalf, said: "It [the Committee] concluded that this was the appropriate and proportionate sanction in this case. The Committee took the view that the likelihood of repetition of dishonest conduct was very low. It had found no ‘attitude of dishonesty’ in the respondent. There were no risks to the welfare or health of animals. The respondent was a good veterinary surgeon and he had shown considerable insight regarding his dishonesty, for example, by actively seeking out Ms Green to tell her the truth.
"The Committee does not condone what the respondent has done. It considers that the public interest requires that there has to be confidence that veterinary surgeons do not fabricate accounts or documents, no matter what their intentions."
She added: "The Committee has therefore determined that suspension for a period of 10 weeks is proportionate in all the circumstances to mark the nature and gravity of the case and is sufficient to maintain public confidence in the profession and to uphold proper standards of conduct and behaviour, and directs the Registrar accordingly."
The Committee’s full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
The new Vetscan Imagyst AI dermatology application analyses impression smears and ear and skin swabs to identify yeast, inflammatory cells and bacteria.
It provides results in about ten minutes, depending on your upload speeds, which VetSurgeon understands is probably how long a dermatologist would take to perform the task (compared to a GP, who might take twice as long, depending on skills, available equipment, volume of tests, etc).
In terms of accuracy, Zoetis says the application is comparable to that of a clinical pathology expert.
In addition, it fires out a report, including images, which can be shared with the client, adding more value to the consultation.
According to a 2006 study, something like 72% of vets' derm diagnosis and treatment recommendations are based on presenting clinical signs and physical examination alone1.
Vetscan Imagyst list price is just shy of £18,000, but there are a variety of commercial deals that can be discussed with your Zoetis Account Manager. Each AI analysis costs in the order of a tenner.
So the question is whether the new system is worth the investment - for the 72% in terms of a more accurate diagnosis over an educated guess, and for the 28% in terms of the time-savings over a manual analysis.
Sophie Duguid, Diagnostics National Veterinary Manager at Zoetis UK said: “The ability to accurately and reliably identify inflammatory cells, bacteria and yeast, at the time of visit can make a huge difference for busy clinics, ensuring better outcomes and happier patients and owners.
"Performing cytology is a critical component of the dermatology work-up, however this can often be challenging for veterinary healthcare teams to deliver given the considerable time pressures in clinical practice.
"Vetscan Imagyst AI dermatology allows clinicians to rapidly detect the presence or absence of skin infection in canine and feline dermatology cases which allows for clinically informed decision making."
Reference
The team at the centre will be led by Dr Ryk Botes (pictured right), a Medivet Branch Partner with a special interest in orthopaedics and, in particular, replacement surgery.
The company says it is investing in specialist equipment to help the team refine current surgical techniques, including a gait analysis walkway which will be used to help diagnose the cause of lameness and be a means to measure improvement in surgical cases objectively. The data it provides will also enable the team to publish its results in peer-reviewed papers.
Ryk, who qualified in South Africa and joined Medivet in 2013, said: "The volume of elbow, hip and knee replacements we undertake is growing rapidly and the creation of this new centre of excellence at Medivet Faversham will enable us to provide an even higher standard of service to our clients and to help develop and refine orthopaedic techniques for use by the wider veterinary community.
"Data from the gait analysis walkway will be particularly useful in sharing our findings in scientific papers. We will also use the data to support an ongoing research project in elbow replacement surgery in partnership with one of the leaders in implant technology based in Zurich, Switzerland.
Hannah, who graduated from the RVC in 2015, was nominated for her dedication to excelling in first-opinion practice through her farm, small animal and equine work as a mixed animal vet in Aberystwyth.
She was selected from a field of more than 100 entrants by the award judges BVA President Malcolm Morley, President of the Royal College of Veterinary Surgeons (RCVS) Melissa Donald, Professor the Lord Trees, Zoetis National Veterinary Manager Jonny Lambert and last year’s winner of the award, Alex Davies.
Hannah said: “This is fantastic! I’m so pleased to accept this award.
"I want to say a huge thanks to my practice for giving me the freedom to explore my passions and enabling me to work with a wide of range of species.
"I want to particularly mention my mentors Dafydd, Phil and Kate, who inspired me to focus on what I love.”
BVA President Malcolm Morley said: “Hannah’s incredible enthusiasm and passion for her work as a mixed-practice vet really made her stand-out to us.
"She is excelling in her work across species, which is challenging enough, but she’s also doing it at a high level.
"It is great to recognise the contribution that Hannah and other first-opinion vets make to our profession."
Salmoporc gives protection against Salmonella Typhimurium and its monophasic variants. It is administered orally to piglets and through subcutaneous injection in sows.
According to the company, Salmoporc is the only live, attenuated salmonella vaccine licensed for pigs in the UK and Ireland.
Ceva says salmonella in UK and Irish herds is the highest in the EU, with a prevalence of 19.5% and 17.5% respectively. It is particularly difficult to control in outdoor herds since the bacteria can survive in soil for a year, even longer in dried dung and has been detected in fields two years after being vacated by pigs.
Outdoor bred, or reared, pigmeat accounts for 12% of retail sales and the majority of this is processed.
Dr Rike Schmelz from Ceva said: "Salmonella is an increasing problem on pig farms and the bacteria are transmitted through breeding pyramids which eventually supply finishing pigs. Clinical cases of diarrhoea often occur after weaning and tend to be treated with antibiotics."
Rike added: "The monophasic variant of S. Typhimurium is already multi-drug resistant and vaccinating pigs can help farmers to substantially reduce their use of expensive antibiotics. In addition, with the removal of zinc oxide at therapeutic levels from the feed in mid-2022, salmonella and other enteric diseases are likely to become more apparent."
Ceva says that by immunising their pigs against S. Typhimurium, farmers will gain an economic benefit from lowered mortality and improved daily liveweight gain (DLWG) among their pigs.
In independent trials at the University of Ghent in Belgium, between three and 29 weeks, vaccinated piglets from three herds gained between 30g and 39g, significantly more per day than unvaccinated controls.
Trials in Germany have shown that, with vaccination of sows and gilts at the top of the breeding pyramid, combined with a competent hygiene programme, it is possible to eliminate salmonella from the supply chain.
Alexander McKinstry and Andrew Rutherford were both charged with writing letters indicating that Rebecca Inman had undertaken an assessment when in fact they had done the assessments themselves, the former without Ms Inman's knowledge, the latter with.
The charges were that all three, who worked at the same practice group in North-West, had been dishonest, misleading and risked undermining procedures designed to promote animal welfare.
At the outset of the hearing, all three admitted the charges against them and the Committee found serious professional misconduct in the case of all admitted charges.
The Committee then considered the sanctions for all three of the respondents.
In the cases against Mr McKinstry and Mr Rutherford, the Committee considered that the conduct was premeditated, that they had an increased position of trust and responsibility as practice directors at the time of the misconduct and that it was a breach of trust for the farm clients.
Additionally, Mr McKinstry had put Dr Inman’s professional reputation in jeopardy by not informing her of his conduct.
In mitigation, the Committee considered that there was no harm or risk of harm to animals, the conduct was not done for personal financial gain, that both had been open and frank in their dealings with the RCVS and had shown insight into their behaviour, and their previous good character and unblemished careers.
Regarding Dr Inman, the aggravating factors were the abuse of her position of trust as a registered mobility scorer and the breach of trust with the farm clients.
In mitigation the Committee considered that it had been an isolated incident involving, from Dr Inman’s point of view, a single telephone call.
It also considered that there was no risk of harm, no personal financial gain, her open and frank admissions in dealings with the RCVS, demonstration of insight, previously unblemished record, and efforts to avoid repeats and remediate past misconduct.
Paul Morris, chairing the Committee and speaking on its behalf, said: “The Committee carefully weighed the demands of the public interest, as well as the previously stated mitigating and aggravating factors and all the particular circumstances before it.
"The Committee concluded that a period of suspension was sufficient and proportionate in this case to meet the need to maintain public confidence in the profession and uphold proper standards.
"It had a sufficient deterrent effect upon others in the profession and was sufficient to mark that the disgraceful conduct was unacceptable.
“The Committee considered all of the factors before it, and decided that given the personal mitigation in this case, as set out above, a period of one month was appropriate and proportionate in all the circumstances."
The full findings of the Disciplinary Committee regarding this case can be found at: www.rcvs.org.uk/disciplinary
Duncan makes three requests of the UK Government:
The first is to make changes to encourage more overseas vets, and specifically the return of EU vets.
The second is to increase funding for UK universities to provide veterinary courses.
The final request is to update the regulatory framework to enable veterinary nurses to expand their role.
Full article: https://ivcevidensia.co.uk/News/duncan-phillips-time-to-overhaul-vet-support